'It's given me so much hope': Pharmac announces breast-cancer drug deal
Metavivor Wiki Mulholland tells the NZ Herald how much the funding of Ibrance (palbociclib) for advanced breast cancer means to her and her fellow Metavivors. PHARMAC announced 15 January 2020 that Ibrance will be funded by PHARMAC from 1 April 2020. Manufacturer Pfizer will provide Ibrance free of charge from now until April.
Date published
Publisher
Keywords / Topics
Media Image
